On BNET: Online porn struggles for profits
BNET Business Network:
BNET
TechRepublic
ZDNet

January 30th, 2009

Proventys stars University chancellor in birth of a salesman

Posted by Dana Blankenhorn @ 9:25 am

Categories: General, Hospital IT, Insurance IT, Medical Equipment, Medical IT, Medical Office Equipment, Research

Tags: Patient, Clinical Trial, Healthcare, Insurance, Business Operations, Corporate Insurance, Dana Blankenhorn

Former Duke Chancellor Dr. Ralph Snyderman has retired from a life of administration and achievement to become a salesman.

He is selling his own start-up, called Proventys, and called while catching a plane to give me his pitch. He sold investors on a tranche of venture investment during December, so he’s off to a good start.

The long-term goal is to give physicians the best choices at the point of care. The near-term goal is to offer this for cancer patients.

The main way Proventys does this is by building virtual decision trees from clinical trial data, then selling the results to insurance carriers and self-insurance pools for use at cancer centers.

“Collect patients’ data as they undergo chemotherapy, before and after, and  mine that data to see what were the most important predictive factors” for success, “that’s the way to do it” he said.

Dr. Snyderman is confident that insurers will gladly pay for a service that gives them greater confidence in a positive result at the lowest possible cost. 

“What we need to look for, given the way the reimbursement system works, are people who have incentives to gain on the bottom line with this, who will share savings with the developer,” he explained.

“Our intention is to start creating proof of concept and revenues by the end of 2009. I believe we can get to profitability by 2011.”

I suggested to Dr. Snyderman that he really must thread a needle here. The system needs FDA approval and health reform may completely transform the model.

“We anticipate and are eager to participate in this wave of health care reform,” he replied. ”They all talk about making medicine more personalized and patient centered. We think we’re going to be able to ride the wave.”

Willy Loman couldn’t have done it better. But Dr. Snyderman is just getting started.

Dana BlankenhornDana Blankenhorn has been a business journalist since 1978, and has covered technology since 1982. He launched the Interactive Age Daily, the first daily coverage of the Internet to launch with a magazine, in September 1994. See his full profile and disclosure of his industry affiliations.

Email Dana Blankenhorn

Subscribe to ZDNet Healthcare via Email alerts or RSS.

  • Talkback
  • Most Recent of 2 Talkback(s)
Clinical trials
That's the reason Proventys is starting with
data from clinical trials, and aiming at cancer.

The clinical trial data can be very complete, as
you note, and cancer is a complex disease... (Read the rest)
Posted by: DanaBlankenhorn Posted on: 01/31/09 You are currently: a Guest | | Terms of Use
Data collection is a challenge  Ken_z | 01/30/09
Clinical trials  DanaBlankenhornZDNet Moderator | 01/31/09

What do you think?

SponsoredWhite Papers, Webcasts, and Downloads

advertisement

Recent Entries

advertisement

Archives

Favorite Links

ZDNet Blogs

White Papers, Webcasts, and Downloads

SmartPlanet

Click Here